The ICMS has assembled a Medical Advisory Board to serve as a leadership role in the continued development of ICMS Clinical Guidelines, Practice Standards, and Adjudication Review for stem cell treatments. The Medical Board is made up of physicians and researchers from academic institutions, hospitals, and private practices around the world. It is the hope of the ICMS that this Board will make certain that the guidelines and practice standards of the Society ensure patient safety through peer oversight and transparency.
A list of members of the Medical Advisory Board can be found HERE.
Click HERE to read the full press release.